Vistagen Therapeutics (VTGN) Non-Current Deferred Revenue (2020 - 2025)
Vistagen Therapeutics' Non-Current Deferred Revenue came in at $176,000 for fiscal Q3 2026 (quarter ended Dec 31, 2025), down 61.2% from $454,000 a year earlier and down 47.6% from the prior quarter.
Vistagen Therapeutics (VTGN) Non-Current Deferred Revenue (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Mar 31, 2025), Vistagen Therapeutics' Non-Current Deferred Revenue was $391,000, down 85.4% from FY2024.
- Non-Current Deferred Revenue carries a four-year compound annual growth rate of -37.1% (FY2021 to FY2025).
- Going back by fiscal year, Non-Current Deferred Revenue was $2.67 million in FY2024 (+15.5%), $2.32 million in FY2023 (+48.6%), $1.56 million in FY2022 (-37.5%) and $2.49 million in FY2021.
- The fiscal Q3 2026 figure represents the lowest quarterly Non-Current Deferred Revenue in data going back to fiscal Q2 2021.
- Year-over-year, Non-Current Deferred Revenue has declined for seven consecutive quarters, with an average decline of 56.1% over the last eight quarters.
- The fastest year-over-year change in Non-Current Deferred Revenue over five years came in fiscal Q3 2023 (growth of 75.5%), and the weakest in fiscal Q4 2025 (a decline of 85.4%).
- Business Quant data shows VTGN's Non-Current Deferred Revenue at $336,000 (Q2 2026), $221,000 (Q1 2026) and $391,000 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 336,000.00 |
| Jun 30, 2025 | 221,000.00 |
| Mar 31, 2025 | 391,000.00 |
| Dec 31, 2024 | 454,000.00 |
| Sep 30, 2024 | 730,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 2.14 Mn |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | 2.49 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.78 Mn |
| Jun 30, 2021 | 2.14 Mn |
| Mar 31, 2021 | 2.49 Mn |
Vistagen Therapeutics Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();